BRKR — Bruker Corporation stock price and chart

BRKR

$55.93+1.01%

as of close, Oct 20, 2026

☾ AH $55.93 +1.01%

Bruker CorporationStock · HealthcareNasdaq Composite · 0.02% of ONEQRussell 3000 · 0.009% of IWVRussell 1000 · 0.009% of IWBUS Stock Market · 0.009% of VTI

PeersBIOGMEDGKOSPODDSNNALB

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDED

20162019202120242026

30.040.050.060.070.080.090.0020.0M40.0M$55.93

2026-10-20

Price$55.93

MA20$56.34

MA50$46.32

Vol7.1M

What would $1,000 invested in BRKR be worth today? →

BRKR returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $55.93
YTD price return: +18.72%
YTD total return: +19.10%
Next earnings: Nov 2, 2026
Market cap: 8.5B2016-12 3.4B2026-10 8.5B+150.8% over the window
Enterprise value: 10.4B
Shares outstanding: 152.4M2016-06 161.5M2026-06 152.4M-5.7% over the window
52W low: $32.37
52W high: $66.98
From 52W high: -16.50%
From 52W low: +72.78%
52W range: 68%

Volume

Rel volume: 0.62×
30D volume: 2.3M
30D $ vol: 138.4M

Fundamentals

Sales (ttm): 3.5B2016-06 1.6B2026-06 3.5B+115.8% over the window
Sales/share: $22.972016-06 $10.042026-06 $22.97+128.8% over the window
EPS (ttm): -$0.472016-06 $0.662026-06 -$0.47-170.9% over the window
FCF (ttm): 93.9M2016-06 169.8M2026-06 93.9M-44.7% over the window
FCF/share: $0.622016-06 $1.052026-06 $0.62-41.4% over the window
Book value/share: $15.752016-06 $4.112026-06 $15.75+283.6% over the window
Net margin: -2.03%2016-06 6.9%2026-06 -2.0%-129.6% over the window
ROE: -2.97%2016-06 16.8%2026-06 -3.0%-117.7% over the window
ROA: -1.18%2016-06 6.5%2026-06 -1.2%-118.2% over the window
Debt / equity: 0.76×2016-06 0.492026-06 0.76+55.4% over the window
Current ratio: 1.852016-06 2.272026-06 1.85-18.7% over the window

Growth (CAGR, ttm) · 10Y

Sales: +1.65%2025-06-30 → 2026-06-303.4B → 3.5B (+1.6% total)+8.83%2023-06-30 → 2026-06-302.7B → 3.5B (+28.9% total)+9.10%2021-06-30 → 2026-06-302.3B → 3.5B (+54.5% total)+8.00%2016-06-30 → 2026-06-301.6B → 3.5B (+115.8% total)
FCF: +90.55%2025-06-30 → 2026-06-3049.3M → 93.9M (+90.5% total)-22.36%2023-06-30 → 2026-06-30200.7M → 93.9M (-53.2% total)-21.33%2021-06-30 → 2026-06-30311.6M → 93.9M (-69.9% total)-5.75%2016-06-30 → 2026-06-30169.8M → 93.9M (-44.7% total)
Shares: +0.42%2025-06-30 → 2026-06-30151.7M → 152.4M (+0.4% total)+1.23%2023-06-30 → 2026-06-30146.9M → 152.4M (+3.7% total)+0.18%2021-06-30 → 2026-06-30151M → 152.4M (+0.9% total)-0.58%2016-06-30 → 2026-06-30161.5M → 152.4M (-5.7% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +1.22%2025-06-30 → 2026-06-30$22.69 → $22.97 (+1.2% total)+7.51%2023-06-30 → 2026-06-30$18.48 → $22.97 (+24.3% total)+8.91%2021-06-30 → 2026-06-30$14.99 → $22.97 (+53.2% total)+8.63%2016-06-30 → 2026-06-30$10.04 → $22.97 (+128.8% total)
FCF/share: +89.75%2025-06-30 → 2026-06-30$0.32 → $0.62 (+89.7% total)-23.31%2023-06-30 → 2026-06-30$1.37 → $0.62 (-54.9% total)-21.47%2021-06-30 → 2026-06-30$2.06 → $0.62 (-70.1% total)-5.20%2016-06-30 → 2026-06-30$1.05 → $0.62 (-41.4% total)
Book value/share: +31.39%2025-06-30 → 2026-06-30$11.99 → $15.75 (+31.4% total)+23.39%2023-06-30 → 2026-06-30$8.38 → $15.75 (+87.9% total)+18.88%2021-06-30 → 2026-06-30$6.63 → $15.75 (+137.4% total)+14.39%2016-06-30 → 2026-06-30$4.11 → $15.75 (+283.6% total)
Dividend/share: -25.85%2025-06-30 → 2026-06-30$0.20 → $0.15 (-25.8% total)-2.49%2023-06-30 → 2026-06-30$0.16 → $0.15 (-7.3% total)-1.50%2021-06-30 → 2026-06-30$0.16 → $0.15 (-7.3% total)+6.31%2016-06-30 → 2026-06-30$0.08 → $0.15 (+84.3% total)
Price: +46.80%2025-10-20 → 2026-10-20$38.11 → $55.93 (+46.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-2.08%2023-10-20 → 2026-10-20$59.57 → $55.93 (-6.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-6.62%2021-10-20 → 2026-10-20$78.75 → $55.93 (-29.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.02%2016-10-19 → 2026-10-20$21.52 → $55.93 (+159.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +47.42%2025-10-20 → 2026-10-20$37.95 → $55.93 (+47.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.69%2023-10-20 → 2026-10-20$58.87 → $55.93 (-5.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-6.29%2021-10-20 → 2026-10-20$77.37 → $55.93 (-27.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+10.45%2016-10-19 → 2026-10-20$20.70 → $55.93 (+170.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -119.6×2016-12 23.272026-10 -119.68-614.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 195.0×2016-12 19.872026-10 -278.48-1501.7% over the window
Fwd P/E: 22.8×
P/S (ttm)Market cap ÷ TTM revenue.: 2.4×2016-12 2.102026-10 2.43+16.1% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.6×2016-12 4.902026-10 3.55-27.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 90.8×2016-12 22.322026-10 90.75+306.6% over the window
EV/EBITDA (fy): 52.0×
EV/Sales (ttm): 3.0×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 1.10%2016-09 4.5%2026-06 1.0%-77.1% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 0.36%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 0.36%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $0.20
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-2.6M) ÷ today's market cap ($8.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -0.03%2016-09 5.7%2026-06 -0.0%-100.5% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-2.6M + TTM dividends $22.6M) ÷ today's market cap ($8.5B). Same caveat as the cash buyback yield.: 0.23%2016-09 6.3%2026-06 0.2%-96.5% over the window

Vs own 10Y history

P/E: 88th
P/OI: 100th
P/S: 19th
P/B: 13th
P/FCF: 90th

Bar = where today’s multiple sits in BRKR’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+1.01%

-0.46%

-8.89%

-0.43%

YTD

+18.72%

+46.76%

-28.98%

Financial statements

Open full BRKR financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

BRKR — Bruker Corporation price, chart and key statistics